Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001257213 | SCV001433741 | likely benign | Nemaline myopathy 2 | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001788434 | SCV002030929 | uncertain significance | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV001788434 | SCV003812191 | uncertain significance | not provided | 2021-09-17 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001257213 | SCV002084066 | uncertain significance | Nemaline myopathy 2 | 2020-02-04 | no assertion criteria provided | clinical testing |